|
    AAVXF U.S.: OTC
    AAVXFUS
    Closed
    Back To Top
    Last Updated: Jul 23, 2021 11:54 a.m. EDT Delayed quote

    $ 35.94

    0.84 2.39%
    Previous Close
    $35.10
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 8 65 Day Avg: 127.46
    6% vs Avg
    35.94 Day Range 36.60
    21.14 52 Week Range 43.97

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    AAVXF Overview

    Performance

    5 Day
    • 2.39%
    1 Month
    • -7.85%
    3 Month
    • 44.98%
    YTD
    • -12.34%
    1 Year
    • 34.30%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 6 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    No Headlines Available

    Abivax S.A.

    Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development comprise of vaccine for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.